Caricamento...
Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor
We administered recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) to four patients with myelodysplastic syndrome (MDS) and three patients with non‐MDS (two malignant lymphoma and one lung cancer) as a part of a phase II trial and analyzed the effects of rhG‐CSF on the neoplastic cell...
Salvato in:
| Pubblicato in: | Jpn J Cancer Res |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Blackwell Publishing Ltd
1989
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5917852/ https://ncbi.nlm.nih.gov/pubmed/2480943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1989.tb01725.x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|